摘要
目的探讨老年急性ST段抬高型心肌梗死(STEMI)患者住院期间二级预防用药的特点及其原因。方法将2006年1～12月就诊的182例STEMI患者根据年龄分为老年组和非老年组,对比分析2组二级预防用药差异。结果老年组STEMI患者β受体阻断药和阿司匹林使用率(分别为51.43%和67.62%)明显低于非老年组(分别为72.73%,89.61%);心功能(Killip分级)≥3级、消化系统合并症/并发症患者比例(分别为34.29%,25.71%)明显高于非老年组(分别为16.88%,12.99%)。结论老年STEMI患者β受体阻断药和阿司匹林使用率均低,心功能差是老年STEMI患者β受体阻断药应用受限的主要原因,消化系统合并症和并发症是老年STEMI患者阿司匹林应用受限的主要原因。
Objective To explore the characteristics and causes of using secondary prevention drugs for elderly patients with acute ST-elevation myocardial infarction （STEMI）. Methods 105 elderly patients （≥60 years） with STEMI in 2006 were retrospectively analyzed for using secondary prevention drugs by comparing with 77 non-elderly patients （ 〈 60 years） with STEMI. Results In elderly group the percentage of using Is-receptor blocker （51.43% ： 72.73% ） and aspirin （67.62% ： 89.61% ）were both significantly lower and the incidence of poor heart function（ ≥ level 3, 34.29% ： 16.88% ） and digestive system abnormalities （25.71% ： 12.99 % ） were both significantly higher. Conclusion IS-receptor blocker and aspirin are rarely used for the elderly STEMI patients, the reasons lie in the poor heart function and digestive system diseases which restrict the use of two drugs.
出处
《医药导报》
CAS
2009年第8期1013-1016,共4页
Herald of Medicine
关键词
心肌梗死
急性
二级预防
老年患者
Myocardial infarction ,acute
Secondary prevention
Elderly patient
